Neo Kumfurt Robocard 2.5/5mg (Pimobendan & Benazepril) Tablets for Dogs
Robocard 2.5/5mg Tablet from Neo Kumfurt is a cardiac combination therapy for dogs, containing pimobendan and benazepril to manage congestive heart failure. Pimobendan enhances heart contractility and dilates vessels while benazepril, an ACE inhibitor, reduces blood pressure and cardiac workload. Palatable chewable tablets ensure easy administration in heart patients.
-
Composition : Pimobendan 2.5 mg or 5 mg (inotropic agent)
Benazepril HCl 5 mg or 10 mg (ACE inhibitor)
Indications :
- Congestive heart failure (CHF) due to AV valvular insufficiency
- Dilated cardiomyopathy (DCM) in dogs (NYHA Class II-IV)
- Mild, moderate, or severe heart failure symptoms
Features :
- Dual action: strengthens heart contractions and reduces vascular resistance
- Improves exercise tolerance and quality of life in CHF dogs
- Synergistic pimobendan-benazepril combination therapy
- Liver-flavored for better compliance
Directions for Use:
-
0.25-0.5 mg pimobendan/kg + 0.5-1 mg benazepril/kg body weight
-
Divide into 2 daily doses (12 hours apart), 1 hour before feeding
-
Oral administration; vet dosage adjustment required
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Description
Robocard 2.5/5mg Tablet from Neo Kumfurt is a cardiac combination therapy for dogs, containing pimobendan and benazepril to manage congestive heart failure. Pimobendan enhances heart contractility and dilates vessels while benazepril, an ACE inhibitor, reduces blood pressure and cardiac workload. Palatable chewable tablets ensure easy administration in heart patients.
-
Composition : Pimobendan 2.5 mg or 5 mg (inotropic agent)
Benazepril HCl 5 mg or 10 mg (ACE inhibitor)
Indications :
- Congestive heart failure (CHF) due to AV valvular insufficiency
- Dilated cardiomyopathy (DCM) in dogs (NYHA Class II-IV)
- Mild, moderate, or severe heart failure symptoms
Features :
- Dual action: strengthens heart contractions and reduces vascular resistance
- Improves exercise tolerance and quality of life in CHF dogs
- Synergistic pimobendan-benazepril combination therapy
- Liver-flavored for better compliance
Directions for Use:
-
0.25-0.5 mg pimobendan/kg + 0.5-1 mg benazepril/kg body weight
-
Divide into 2 daily doses (12 hours apart), 1 hour before feeding
-
Oral administration; vet dosage adjustment required
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.





















